Sector
HealthcareOpen
₹32.39Prev. Close
₹31Turnover(Lac.)
₹1.47Day's High
₹33Day's Low
₹3052 Week's High
₹49.552 Week's Low
₹25Book Value
₹9.85Face Value
₹10Mkt Cap (₹ Cr.)
31.34P/E
0EPS
0Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 10.29 | 10.29 | 10.29 | 9.29 |
Preference Capital | 5.89 | 5.79 | 5.7 | 5.61 |
Reserves | -2.47 | -2.43 | -6.91 | -10.42 |
Net Worth | 13.71 | 13.65 | 9.08 | 4.48 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 15.2 | 8.41 | 4.35 | 0.75 |
yoy growth (%) | 80.66 | 93.13 | 474.3 | 0 |
Raw materials | -2.63 | -1.98 | -1.3 | -0.14 |
As % of sales | 17.32 | 23.61 | 29.87 | 18.73 |
Employee costs | -4.02 | -4.94 | -3.42 | -1.61 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 1.38 | -4.21 | -5.58 | -2.72 |
Depreciation | -1.44 | -1.66 | -1.12 | -0.19 |
Tax paid | 0 | -0.02 | 0 | 0 |
Working capital | 0.85 | 0.84 | -1.33 | -3.37 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 80.66 | 93.13 | 474.3 | 0 |
Op profit growth | -292.22 | -52.81 | 50.34 | 979.16 |
EBIT growth | -171.01 | -33.01 | 93.64 | -3,067.65 |
Net profit growth | -132.56 | -24.03 | 104.87 | -10,028.19 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,385 | 90.85 | 91,806.5 | 238.8 | 0.09 | 1,894.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 920.05 | 130.13 | 89,420.8 | 241.77 | 0.16 | 610.11 | 79.02 |
Fortis Healthcare Ltd FORTIS | 480.8 | 293.17 | 36,298.39 | 68.33 | 0.21 | 307.48 | 120.36 |
Global Health Ltd MEDANTA | 1,202.5 | 89.61 | 32,288.01 | 92.24 | 0 | 578.65 | 106.09 |
Narayana Hrudayalaya Ltd NH | 1,242 | 59.8 | 25,381.61 | 158.09 | 0.32 | 846.31 | 90.04 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & CEO
Pankaj Jashwant Shah
Non Executive Director
Arvind Karsandas Bhanushali
Independent Director
Mangala Radha Krishnan Prabhu
Chairman & Independent Directo
Haseeb Drabu
Non Executive Director
Nikunj Mange
Independent Director
Subhash Raghunath Salunke
Independent Director
A C Mahajan
Independent Director
Manas Mengar
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Aspira Pathlab & Diagnostics Ltd
Summary
Aspira Pathlab & Diagnostics Limited is a public limited company incorporated in July 03rd, 1973. The Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.During the year, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of Ankur Pathology Laboratory. The Company issued 2943000 equity shares of Rs. 10/- each at an issue price of Rs. 17/- per share (including share premium of Rs. 7/- per share) on preferential basis to promoters & group of strategic investors not forming part of the promoter. The allotment was made on 19th November 2016 & listing & trading approval is awaited. The paid-up capital as on 31st March 2017 was 5193000 equity shares of Rs. 10/- each.The Company has changed its object clause on 10th August 2016; its present name was changed on 16th November 2016 & registered office of the company was shifted from State of West Bengal to State of Maharashtra, vide order dated 18th November, 2016 & company again shifted its registered office within the city limit of Mumbai on 17th March, 2017.During the year 2017, the Company applied to BSE Limited on 27th July 2017 under Direct Listing norms of BSE Limited for listing & trading of its securities at BS
Read More
The Aspira Pathlab & Diagnostics Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹30.45 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aspira Pathlab & Diagnostics Ltd is ₹31.34 Cr. as of 22 Jul ‘24
The PE and PB ratios of Aspira Pathlab & Diagnostics Ltd is 0 and 3.15 as of 22 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Aspira Pathlab & Diagnostics Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Aspira Pathlab & Diagnostics Ltd is ₹25 and ₹49.5 as of 22 Jul ‘24
Aspira Pathlab & Diagnostics Ltd's CAGR for 5 Years at -3.21%, 3 Years at -6.56%, 1 Year at 12.73%, 6 Month at -0.58%, 3 Month at 2.82% and 1 Month at 9.93%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.